59 related articles for article (PubMed ID: 16465657)
1. Natural history of mild-moderate pulmonary hypertension and the risk factors for severe pulmonary hypertension in scleroderma.
Chang B; Schachna L; White B; Wigley FM; Wise RA
J Rheumatol; 2006 Feb; 33(2):269-74. PubMed ID: 16465657
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary phenotype in systemic sclerosis associated pulmonary hypertension.
Cajas Santana LJ; Correa Giraldo A; Torres MC
Reumatol Clin (Engl Ed); 2024 May; 20(5):243-248. PubMed ID: 38880552
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis manifestations and clinical outcomes in Hispanics/Latinos of the American Southwest.
Nunez SE; Ariza-Hutchinson A; Fields RA; Vondenberg JA; Patel RA; Emil NS; Muruganandam M; Gibb JI; Poole JL; Sibbitt WL
J Scleroderma Relat Disord; 2022 Jun; 7(2):135-143. PubMed ID: 35585952
[TBL] [Abstract][Full Text] [Related]
4. A review of exercise pulmonary hypertension in systemic sclerosis.
Shaikh F; Anklesaria Z; Shagroni T; Saggar R; Gargani L; Bossone E; Ryan M; Channick R; Saggar R
J Scleroderma Relat Disord; 2019 Oct; 4(3):225-237. PubMed ID: 35382504
[TBL] [Abstract][Full Text] [Related]
5. Outcomes and Risk Factors of Systolic Pulmonary Artery Pressure Progression in Patients with Systemic Rheumatic Diseases: Follow-up Results from a Korean Registry.
Seo MR; Yeo J; Ryu HJ; Choi HJ; Ko KP; Baek HJ
Arch Rheumatol; 2020 Dec; 35(4):558-567. PubMed ID: 33758812
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Key Genes Associated With Systemic Sclerosis-Related Pulmonary Hypertension.
Zheng JN; Li Y; Yan YM; Shi H; Zou TT; Shao WQ; Wang Q
Front Genet; 2020; 11():816. PubMed ID: 32793290
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease.
Niklas K; Niklas A; Mularek-Kubzdela T; Puszczewicz M
Medicine (Baltimore); 2018 Jul; 97(28):e11437. PubMed ID: 29995796
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilic Alveolitis and High Serum Pro-Brain Natriuretic Peptide Level may be Indicators of Pulmonary Functional Impairment in Connective Tissue Disorders.
Unculu S; Diken ÖE; Çiledağ A; Ikincioğullari A; Karnak D; Kayacan O; Turgay M
Arch Rheumatol; 2016 Mar; 31(1):14-23. PubMed ID: 29900993
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary vascular and cardiac impairment in interstitial lung disease.
Panagiotou M; Church AC; Johnson MK; Peacock AJ
Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28096284
[TBL] [Abstract][Full Text] [Related]
10. Risk of Digital Vascular Events in Scleroderma Patients Who Have Both Anticentromere and Anti-Interferon-Inducible Protein 16 Antibodies.
McMahan ZH; Wigley FM; Casciola-Rosen L
Arthritis Care Res (Hoboken); 2017 Jun; 69(6):922-926. PubMed ID: 27389713
[TBL] [Abstract][Full Text] [Related]
11. Subspecificities of anticentromeric protein A antibodies identify systemic sclerosis patients at higher risk of pulmonary vascular disease.
Perosa F; Favoino E; Favia IE; Vettori S; Prete M; Corrado A; Cantatore FP; Valentini G
Medicine (Baltimore); 2016 Jun; 95(25):e3931. PubMed ID: 27336883
[TBL] [Abstract][Full Text] [Related]
12. Connective tissue disease-associated pulmonary arterial hypertension.
Condliffe R; Howard LS
F1000Prime Rep; 2015; 7():06. PubMed ID: 25705389
[TBL] [Abstract][Full Text] [Related]
13. Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases.
Boueiz A; Hassoun PM
Ann Thorac Med; 2014 Jul; 9(Suppl 1):S26-37. PubMed ID: 25076994
[TBL] [Abstract][Full Text] [Related]
14. Relationship of main pulmonary artery diameter to pulmonary arterial pressure in scleroderma patients with and without interstitial fibrosis.
McCall RK; Ravenel JG; Nietert PJ; Granath A; Silver RM
J Comput Assist Tomogr; 2014; 38(2):163-8. PubMed ID: 24448503
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology of pulmonary arterial hypertension.
Jiang X; Jing ZC
Curr Hypertens Rep; 2013 Dec; 15(6):638-49. PubMed ID: 24114080
[TBL] [Abstract][Full Text] [Related]
16. Systemic sclerosis-associated pulmonary arterial hypertension.
Chaisson NF; Hassoun PM
Chest; 2013 Oct; 144(4):1346-1356. PubMed ID: 24081346
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary Arterial Hypertension-A Deadly Complication of Systemic Sclerosis.
Pankey EA; Epps M; Nossaman BD; Hyman AL; Kadowitz PJ
J Clin Rheumatol Musculoskelet Med; 2010 Dec; 1(2):11-20. PubMed ID: 23626904
[TBL] [Abstract][Full Text] [Related]
18. Scleroderma lung disease.
Solomon JJ; Olson AL; Fischer A; Bull T; Brown KK; Raghu G
Eur Respir Rev; 2013 Mar; 22(127):6-19. PubMed ID: 23457159
[No Abstract] [Full Text] [Related]
19. Epidemiology and risk factors for pulmonary hypertension in systemic sclerosis.
Yaqub A; Chung L
Curr Rheumatol Rep; 2013 Jan; 15(1):302. PubMed ID: 23292818
[TBL] [Abstract][Full Text] [Related]
20. Systemic sclerosis--challenges for clinical practice.
McMahan ZH; Hummers LK
Nat Rev Rheumatol; 2013 Feb; 9(2):90-100. PubMed ID: 23147899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
